SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-17-000622
Filing Date
2017-06-26
Accepted
2017-06-26 16:26:41
Documents
1
Period of Report
2017-06-22

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT abingworth_fm4jun222017.html 4  
1 OWNERSHIP DOCUMENT abingworth_fm4jun222017.xml 4 5681
  Complete submission text file 0000905718-17-000622.txt   7203
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Issuer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Reporting) CIK: 0001397144 (see all company filings)

State of Incorp.: X0 | Fiscal Year End: 0630
Type: 4 | Act: 34 | File No.: 001-36694 | Film No.: 17930119